logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Platinum-sensitive recurrent ovarian cancer: chemotherapy-bevacizumab combo tops standard

Shows superior survival in phase 3 AGO-OVAR 2.21 study.